ANGN Insider Trading Activity and SEC Form 4 Filings
ANGN insider trading summary
No open-market insider purchases or sales of Angion Biomedica Corp. (ANGN) have been reported on SEC Form 4 in the past 12 months.
Latest ANGN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 25, 2022 | Jay Venkatesan | See Remarks | Buy | $14K (11,313 @ $1.25) |
| May 24, 2022 | Jay Venkatesan | See Remarks | Buy | $40K (32,200 @ $1.24) |
| May 20, 2022 | Jay Venkatesan | See Remarks | Buy | $62K (50,000 @ $1.23) |
| May 20, 2022 | Allen Nissenson | Director | Buy | $2K (2,037 @ $1.18) |
| May 19, 2022 | Allen Nissenson | Director | Buy | $9K (7,346 @ $1.16) |
| Dec 28, 2021 | Jay Venkatesan | See Remarks | Buy | $560K (210,337 @ $2.66) |
| Dec 27, 2021 | Jay Venkatesan | See Remarks | Buy | $171K (66,907 @ $2.55) |
| Dec 20, 2021 | John F. Neylan | See Remarks | Sell | $938 (358 @ $2.62) |
| Dec 20, 2021 | Jay Venkatesan | See Remarks | Buy | $9K (3,527 @ $2.54) |
| Dec 17, 2021 | Jay Venkatesan | See Remarks | Buy | $35K (13,742 @ $2.54) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.